From the period of 2022 to 2028, the Global Facial Injectable Market is expected to reach USD 7.5 Billion in terms of revenue, growing at a Compound Annual Growth Rate (CAGR) of 9.20%.
Facial fillers are chemicals that are injected into the skin to smooth wrinkles and hide them. A face filler injection is usually done as an outpatient surgery using numbing drugs. In recent years, there has been an increase in demand for face injectables due to a greater focus on physical attractiveness among consumers. Increased awareness of minimally invasive procedures as a result of different beauty campaigns undertaken by leading industry participants is another factor driving market expansion. Patients are increasingly choosing cosmetic surgery since it allows them to recover at home. As a result, the market experienced a surge during the epidemic, and this tendency is projected to continue. Additionally, during the projection period, the market is likely to be driven by increased social media exposure, rising effectiveness, and approvals for face injectables, as well as an increasing desire among the population to seem aesthetically appealing and youthful.
Key Highlights from the Report
- On the basis of Product, the market is segmented into Collagen, Hyaluronic Acid (HA), Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), and Polymer Fillers. In 2021, the botulinum toxin type A category led the market, accounting for the majority of revenue. Fillers and injectables, such as Botox, are becoming increasingly popular among middle-aged women who want to reverse the effects of aging. During the projection period, the Hyaluronic Acid (HA) segment is expected to grow at the quickest rate. It is well-known for its capacity to retain moisture in the skin, making it appear healthier. HA contains a moisture-binding property that aids in the enhancement and maintenance of the critical moisture necessary for facial plumpness. Cosmetic-grade HA has a low molecular weight, which allows it to penetrate deep into the epidermis, holding water in the cells and releasing antioxidants that assist to slow down the aging process.
- On the basis of Application, the market is segmented into Aesthetics and Therapeutics. In 2021, the aesthetics category led the market, accounting for the majority of sales. The increased usage of facial injectables for aesthetic operations such as facial lines, wrinkles on the face, and lip lines, to mention a few, has fueled this expansion. The industry is predicted to rise due to factors such as increased awareness of cosmetic procedures and rising disposable income. An increase in the usage of facial injectables for parentheses lines, facial wrinkles, lip lines, lip augmentation, lip border restoration, perioral lines, and crow's feet lines is predicted to contribute to market expansion.
- Asia Pacific is the fastest regional segment in terms of growth. India, Australia, and South Korea are among the countries that support the region. In these developing countries, a growing emphasis on physical attractiveness is projected to drive demand for Facial Injectable treatments. During the predicted period, India is expected to be the fastest-growing country. Other growth drivers for this region include rising disposable income and greater medical tourism.
Rising Demand for Facial Injectables to Enhance Aesthetic Beauty is Expected to Drive Growth of the Global Facial Injectables Market
Aesthetic therapies improve appearance through the least invasive cosmetic procedures. Cosmetic product demand has increased as the demand for minimally invasive cosmetic procedures has increased. Aesthetic medicine is gaining ground in emerging nations, since people see it as a normal element of health care, owing to the desire to retain a natural and healthy appearance. Furthermore, increased promotional efforts, fast-improving healthcare infrastructure, and rising disposable income of the population are all likely to fuel the expansion of the facial injectables market.
Side Effects Associated with Facial Injectables
The market for facial injectables is projected to be hampered by the negative effects associated with dermal injectables over the forecast period. The injection technique used by the healthcare provider, for example, can influence whether the patient has bruising and swelling. Rapid filler injection, the fanning method, and the use of large amounts of filler have all been proven to enhance the risk of bruising and edoema. Furthermore, if the filler is injected too superficially, it can create a bluish discoloration of the skin covering the filler in some cases.
Over the projection period, North America is expected to have tremendous growth. Higher awareness about aesthetic surgical procedures, technological advancements in cosmetic procedures, the presence of key market players, the growing geriatric population, and demand for non-invasive aesthetic procedures are some of the factors driving market growth in the North American region. The regulatory environment, the availability of modern medical technology and infrastructure, and favorable reimbursement policies all contribute to the market's growth in this region.